CEREBRAL ATHEROSCLEROSIS

CEREBRAL ATHEROSCLEROSIS was reported 39 times

CEREBRAL ATHEROSCLEROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 1 0.0003
1 Photoenhancer [EPC] 1 0.0003
2 Central alpha-2 Adrenergic Agonist [EPC] 2 0.0000
3 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 1 0.0000
4 Leukotriene Receptor Antagonist [EPC] 1 0.0000
5 Phenothiazine [EPC] 1 0.0000
6 Cardiac Glycoside [EPC] 2 0.0000
7 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
8 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
9 Aromatic Amino Acid [EPC] 1 0.0000
10 Sulfonylurea [EPC] 2 0.0000
11 Thiazide Diuretic [EPC] 3 0.0000
12 Platelet Aggregation Inhibitor [EPC] 8 0.0000
13 HER2/neu Receptor Antagonist [EPC] 1 0.0000
14 Loop Diuretic [EPC] 6 0.0000
15 beta-Adrenergic Blocker [EPC] 4 0.0000
16 Topoisomerase Inhibitor [EPC] 1 0.0000
17 Aldosterone Antagonist [EPC] 2 0.0000
18 Microtubule Inhibitor [EPC] 2 0.0000
19 Nitrate Vasodilator [EPC] 1 0.0000
20 HMG-CoA Reductase Inhibitor [EPC] 4 0.0000
21 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
22 Parathyroid Hormone Analog [EPC] 1 0.0000
23 Atypical Antipsychotic [EPC] 4 0.0000
24 Nonsteroidal Anti-inflammatory Drug [EPC] 11 0.0000
25 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
26 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
27 Benzodiazepine [EPC] 5 0.0000
28 alpha-Adrenergic Blocker [EPC] 1 0.0000
29 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
30 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
31 Mood Stabilizer [EPC] 1 0.0000
32 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
33 Alkylating Drug [EPC] 1 0.0000
34 Opioid Agonist [EPC] 1 0.0000
35 Platinum-based Drug [EPC] 1 0.0000
36 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
37 Osmotic Laxative [EPC] 1 0.0000
38 Insulin Analog [EPC] 1 0.0000
39 Corticosteroid [EPC] 2 0.0000
40 Tumor Necrosis Factor Blocker [EPC] 1 0.0000